根据临床试验结果，Ｐｒｏｇｅｎｉｃｓ制药公司的混合神经节苷脂结合疫苗（ＭＧＶ）可引发抗体作用于肿瘤细胞的两种不同靶点。 该疫苗的作用目的是：通过刺激形成抗ＧＭ２和ＧＤ２神经节苷脂的抗体，激起人体免疫系统以调控或根除癌症细胞，且不损伤正常组织。多种常见癌症包 Based on clinical trial results, Progenics Pharmaceuticals’ mixed ganglioside conjugate vaccine (MGV) elicited antibodies that act on two different targets of tumor cells. The purpose of this vaccine is to stimulate the body’s immune system to regulate or eradicate cancer cells by stimulating the formation of antibodies against GM2 and GD2 gangliosides without damaging normal tissues. A variety of common cancer packages